Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation

dc.contributor.authorChen, Yinyin
dc.contributor.authorRen, Daoyuan
dc.contributor.authorGuan, Xingmin
dc.contributor.authorYang, Hsin‑Jung
dc.contributor.authorLiu, Ting
dc.contributor.authorTang, Richard
dc.contributor.authorHo, Hao
dc.contributor.authorJin, Hang
dc.contributor.authorZeng, Mengsu
dc.contributor.authorDharmakumar, Rohan
dc.contributor.departmentRadiology and Imaging Sciences, School of Medicine
dc.date.accessioned2025-01-21T13:38:46Z
dc.date.available2025-01-21T13:38:46Z
dc.date.issued2021-09-30
dc.description.abstractBackground: T2* cardiovascular magnetic resonance (CMR) is commonly used in the diagnosis of intramyocardial hemorrhage (IMH). For quantifying IMH with T2* CMR, despite the lack of consensus studies, two different methods [subject-specific T2* (ssT2*) and absolute T2* thresholding (aT2* < 20 ms)] are interchangeably used. We examined whether these approaches yield equivalent information. Methods: ST elevation myocardial infarction (STEMI) patients (n = 70) were prospectively recruited for CMR at 4-7 days post revascularization and for 6-month follow up (n = 43). Canines studies were performed for validation purposes, where animals (n = 20) were subject to reperfused myocardial infarction (MI) and those surviving the MI (n = 16) underwent CMR at 7 days and 8 weeks and then euthanized. Both in patients and animals, T2* of IMH and volume of IMH were determined using ssT2* and aT2* < 20 ms. In animals, ex-vivo T2* CMR and mass spectrometry for iron concentration ([Fe]Hemo) were determined on excised myocardial sections. T2* values based on ssT2* and absolute T2* threshold approaches were independently regressed against [Fe]Hemo and compared. A range of T2* cut-offs were tested to determine the optimized conditions relative to ssT2*. Results: While both approaches showed many similarities, there were also differences. Compared to ssT2*, aT2* < 20 ms showed lower T2* and volume of IMH in patients and animals independent of MI age (all p < 0.005). While T2* determined from both methods were highly correlated against [Fe]Hemo (R2 = 0.9 for both), the slope of the regression curve for ssT2* was significantly larger as compared to aT2* < 20 ms (0.46 vs. 0.32, p < 0.01). Further, slightly larger absolute T2* cut-offs (patients: 23 ms; animals: 25 ms) showed similar IMH characteristics compared to ssT2*. Conclusion: Current quantification methods have excellent capacity to identify IMH, albeit the T2*of IMH and volume of IMH based on aT2* < 20 ms are smaller compared to ssT2*. Thus the method used to quantify IMH from T2* CMR may influence the diagnosis for IMH.
dc.eprint.versionFinal published version
dc.identifier.citationChen Y, Ren D, Guan X, et al. Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation [published correction appears in J Cardiovasc Magn Reson. 2022 Feb 7;24(1):11. doi: 10.1186/s12968-021-00821-5]. J Cardiovasc Magn Reson. 2021;23(1):104. Published 2021 Sep 30. doi:10.1186/s12968-021-00779-4
dc.identifier.urihttps://hdl.handle.net/1805/45323
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1186/s12968-021-00779-4
dc.relation.journalJournal of Cardiovascular Magnetic Resonance
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectMyocardial infarction
dc.subjectHemorrhage
dc.subjectIron
dc.subjectMass spectrometry
dc.titleQuantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Chen2021Quantification-CCBY.pdf
Size:
3.92 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: